Evidence map›Paper›PMID 42709878›Full record

ArticlePLoS biology2026

Discovery Stack Pilot demonstrates the feasibility and outcomes of a scientist-designed peer-review model that separates quality and impact.

Maureen A McGargill, Beiyun C Liu, Michael S Kuhns, Daniel Mucida, Isabella Rauch, Lauren B Rodda, Meghan A Koch, Hugo Gonzalez Velozo, Ken Cadwell, Tanya S Freedman and 7 more

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Maureen A McGargillSolving For Science, San Francisco, California, United States of America.ORCID https://orcid.org/0000-0002-0916-0372
Beiyun C LiuStrategic Communication Education & Outreach, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Michael S KuhnsDepartment of Immunobiology, The University of Arizona, Tucson, Arizona, United States of America.ORCID https://orcid.org/0000-0002-0403-6313
Daniel MucidaLaboratory of Mucosal Immunology, Rockefeller University, New York, New York, United States of America.ORCID https://orcid.org/0000-0002-0000-0452
Isabella RauchDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, United States of America.ORCID https://orcid.org/0000-0003-1897-5693
Lauren B RoddaDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, United States of America.ORCID https://orcid.org/0000-0001-7763-8166
Meghan A KochBasic Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-9539-4027
Hugo Gonzalez VelozoCentro Basal Ciencia & Vida, Fundación Ciencia & Vida, Santiago, Chile.ORCID https://orcid.org/0000-0003-2183-3637
Ken CadwellDivision of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.ORCID https://orcid.org/0000-0002-5860-0661
Tanya S FreedmanDepartment of Pharmacology, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID https://orcid.org/0000-0001-5168-5829
Tiffany C ScharschmidtDepartment of Dermatology, University of California, San Francisco, California, United States of America.ORCID https://orcid.org/0000-0001-5517-089X
Richard SeveropenRxiv, Davis, California, United States of America.ORCID https://orcid.org/0000-0001-6478-931X
Jose Ordovas-MontanesDivision of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-5444-5601
Sara SulimanUCSF Bakar ImmunoX Initiative and Department of Pathology, University of California, San Francisco, San Francisco, California, United States of America.ORCID https://orcid.org/0000-0002-5154-576X
Andrew OberstDepartment of Immunology, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-9500-7912
Brooke RunnetteSolving For Science, San Francisco, California, United States of America.
Matthew F KrummelUCSF Bakar ImmunoX Initiative and Department of Pathology, University of California, San Francisco, San Francisco, California, United States of America.ORCID https://orcid.org/0000-0001-7915-3533

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peer review serves as the cornerstone of scientific quality control. Yet, the current journal-centric system is hindered by long timelines, high publication costs, inconsistent review quality, systemic biases, and editorial gatekeeping. Notably, the system relies on misaligned measures of impact that are tethered to journal branding and conflate scientific rigor (Quality) with perceived significance (Impact). Here, we report findings from the Discovery Stack Pilot Study, which tested a scientist-designed, journal-independent peer review model. The Discovery Stack model integrates in-line reviewer comments to promote constructive feedback and separately evaluates scientific Quality and Impact using defined criteria. To examine feasibility and effectiveness, manuscripts were reviewed in parallel with traditional journal review. A total of 162 reviews were completed, and survey data from 86 participants were analyzed. The results showed that reviewers effectively evaluated Quality and Impact as separate dimensions, with Quality scores being more consistent across reviewers than Impact scores. Participants strongly supported the core elements of the Discovery Stack model and expressed enthusiasm for its broader adoption to enhance transparency, efficiency, and value in peer review. Future studies will explore integrating this model into a digital platform for reviewing and curating scientific discoveries to improve the production and dissemination of high-quality research.

Indexed as

Peer ReviewPeer Review, ResearchFeasibility StudiesHumansPilot ProjectsQuality Control

Identifiers

PMID42709878
PMCPMC13614658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.